276 related articles for article (PubMed ID: 25816542)
1. Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
Kiatchoosakun P; Jirapradittha J; Panthongviriyakul MC; Khampitak T; Yongvanit P; Boonsiri P
J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S82-8. PubMed ID: 25816542
[TBL] [Abstract][Full Text] [Related]
2. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
Meyer S; Gortner L;
Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
[TBL] [Abstract][Full Text] [Related]
3. Vitamin A status after prophylactic intramuscular vitamin A supplementation in extremely low birth weight infants.
Chabra S; Mayock DE; Zerzan J; Bittner R; Neufeld MD; Gleason CA
Nutr Clin Pract; 2013 Jun; 28(3):381-6. PubMed ID: 23462416
[TBL] [Abstract][Full Text] [Related]
4. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S; Bay J; Franz AR; Ehrhardt H; Klein L; Petzinger J; Binder C; Kirschenhofer S; Stein A; Hüning B; Heep A; Cloppenburg E; Muyimbwa J; Ott T; Sandkötter J; Teig N; Wiegand S; Schroth M; Kick A; Wurm D; Gebauer C; Linnemann K; Kittel J; Wieg C; Kiechl-Kohlendorfer U; Schmidt S; Böttger R; Thomas W; Brevis Nunez F; Stockmann A; Kriebel T; Müller A; Klotz D; Morhart P; Nohr D; Biesalski HK; Giannopoulou EZ; Hilt S; Poryo M; Wagenpfeil S; Haiden N; Ruckes C; Ehrlich A; Gortner L;
Lancet Respir Med; 2024 Jul; 12(7):544-555. PubMed ID: 38643780
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of vitamin A in the prevention of complications of prematurity.
Uberos J; Miras-Baldo M; Jerez-Calero A; Narbona-López E
Pediatr Neonatol; 2014 Oct; 55(5):358-62. PubMed ID: 24582166
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A Supplementation for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants: An Update.
Schwartz E; Zelig R; Parker A; Johnson S
Nutr Clin Pract; 2017 Jun; 32(3):346-353. PubMed ID: 28537511
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.
Shenai JP; Kennedy KA; Chytil F; Stahlman MT
J Pediatr; 1987 Aug; 111(2):269-77. PubMed ID: 3302193
[TBL] [Abstract][Full Text] [Related]
8. Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.
Rysavy MA; Li L; Tyson JE; Jensen EA; Das A; Ambalavanan N; Laughon MM; Greenberg RG; Patel RM; Pedroza C; Bell EF;
J Pediatr; 2021 Sep; 236():78-85.e5. PubMed ID: 34004189
[TBL] [Abstract][Full Text] [Related]
9. Early vs delayed vitamin A supplementation in very-low-birth-weight infants.
Robbins ST; Fletcher AB
JPEN J Parenter Enteral Nutr; 1993; 17(3):220-5. PubMed ID: 8505826
[TBL] [Abstract][Full Text] [Related]
10. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.
Pearson E; Bose C; Snidow T; Ransom L; Young T; Bose G; Stiles A
J Pediatr; 1992 Sep; 121(3):420-7. PubMed ID: 1517921
[TBL] [Abstract][Full Text] [Related]
11. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
[TBL] [Abstract][Full Text] [Related]
12. Plasma retinol-binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia.
Shenai JP; Rush MG; Stahlman MT; Chytil F
J Pediatr; 1990 Apr; 116(4):607-14. PubMed ID: 2108233
[TBL] [Abstract][Full Text] [Related]
13. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
14. Vitamin A deficiency and severe bronchopulmonary dysplasia in very low birthweight infants.
Verma RP; McCulloch KM; Worrell L; Vidyasagar D
Am J Perinatol; 1996 Oct; 13(7):389-93. PubMed ID: 8960606
[TBL] [Abstract][Full Text] [Related]
15. Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? The NICHD Neonatal Research Network.
Kennedy KA; Stoll BJ; Ehrenkranz RA; Oh W; Wright LL; Stevenson DK; Lemons JA; Sowell A; Mele L; Tyson JE; Verter J
Early Hum Dev; 1997 Jul; 49(1):19-31. PubMed ID: 9179535
[TBL] [Abstract][Full Text] [Related]
16. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants.
Ambalavanan N; Wu TJ; Tyson JE; Kennedy KA; Roane C; Carlo WA
J Pediatr; 2003 Jun; 142(6):656-61. PubMed ID: 12838194
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
18. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcome data of very low birth weight infants treated with less invasive surfactant administration in comparison to intubation and mechanical ventilation in the clinical setting of a cross-sectional observational multicenter study.
Langhammer K; Roth B; Kribs A; Göpel W; Kuntz L; Miedaner F
Eur J Pediatr; 2018 Aug; 177(8):1207-1217. PubMed ID: 29808237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
